Biondvax Files Registration Statement

The Company hereby announces that on December 29, 2014, the Company filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to a proposed offering of American Depositary Shares in the United States. The timing of the offering, the number of shares to be offered and the price range for the proposed offering have not yet been determined.A registration statement related to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective, and there is no guarantee that this submission of such registration statement will result in the completion of the proposed offering. The registration statement can be accessed through the SEC’s website at www.sec.gov.This immediate report does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor may there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.